Author

G. Timelthaler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

A. de Bruin· 1 shared A. Tiefenbacher· 1 shared A. Villunger· 1 shared B. H. Ramsahoye· 1 shared B. Westendorp· 1 shared C. Bock· 1 shared C. H. Dietz· 1 shared C. Seiser· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. de Bruin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PIDDosome-induced p53-activation for ploidy restriction facilitates hepatocarcinogenesis

V. C. Sladky, K. Knapp, T. G. Szabo, L. Bongiovanni, H. van den Bos, D. C. J. Spierings, B. Westendorp, T. Stojakovic, H. Scharnagl, G. Timelthaler, K. Tsuchia, M. Pinter, F. Foijer, A. de Bruin, T. Reiberger, , A. Villunger

This study shows that PIDDosome-mediated ploidy restriction prevents hepatocellular carcinoma by reducing tumor burden and that low ploidy predicts poor survival in HCC patients.

bioRxiv · May 13, 2020 · PreprintCancer Biology

Requirement of DNMT1 to orchestrate epigenomic reprogramming during NPM-ALK driven T cell lymphomagenesis

E. Redl, R. Sheibani-Tezerji, P. Hamminger, G. Timelthaler, M. R. Hassler, S. Lagger, T. Dillinger, L. Hofbauer, M. Zrimsek, A. Tiefenbacher, M. Kothmayer, C. H. Dietz, B. H. Ramsahoye, L. Kenner, C. Bock, , G. Egger

This study shows that DNMT1 is essential for maintaining tumor-specific methylation during NPM-ALK driven T cell lymphomagenesis, despite oncogenic signaling.

bioRxiv · Apr 9, 2020 · PreprintCancer Biology